The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032.
Department of Immunology, University of Connecticut School of Medicine, Farmington, CT 06030; and.
J Immunol. 2018 Sep 1;201(5):1586-1598. doi: 10.4049/jimmunol.1701616. Epub 2018 Jul 18.
Developing precise and efficient gene editing approaches using CRISPR in primary human T cell subsets would provide an effective tool in decoding their functions. Toward this goal, we used lentiviral CRISPR/Cas9 systems to transduce primary human T cells to stably express the Cas9 gene and guide RNAs that targeted either coding or noncoding regions of genes of interest. We showed that multiple genes (, , ) could be simultaneously and stably deleted in naive, memory, effector, or regulatory T cell (Treg) subsets at very high efficiency. Additionally, nuclease-deficient Cas9, associated with a transcriptional activator or repressor, can downregulate or increase expression of genes in T cells. For example, expression of glycoprotein A repetitions predominant (GARP), a gene that is normally and exclusively expressed on activated Tregs, could be induced on non-Treg effector T cells by nuclease-deficient Cas9 fused to transcriptional activators. Further analysis determined that this approach could be used in mapping promoter sequences involved in gene transcription. Through this CRISPR/Cas9-mediated genetic editing we also demonstrated the feasibility of human T cell functional analysis in several examples: 1) deletion inhibited T cell apoptosis upon reactivation; 2) deletion of , a Ca release-activated channel, abolished Ca influx and cytokine secretion, mimicking natural genetic mutations in immune-deficient patients; and 3) transcriptional activation of or expression enhanced cytokine signaling by IL-2 or IL-7, respectively. Taken together, application of the CRISPR toolbox to human T cell subsets has important implications for decoding the mechanisms of their functional outputs.
利用 CRISPR 在原代人 T 细胞亚群中开发精确和高效的基因编辑方法将提供一种解码其功能的有效工具。为了实现这一目标,我们使用慢病毒 CRISPR/Cas9 系统转导原代人 T 细胞,使其稳定表达 Cas9 基因和靶向感兴趣基因的编码或非编码区域的 guide RNA。我们表明,多种基因(、、)可以在幼稚、记忆、效应或调节性 T 细胞(Treg)亚群中以非常高的效率同时稳定删除。此外,与转录激活剂或抑制剂相关的无核酸酶 Cas9 可以下调或增加 T 细胞中基因的表达。例如,糖蛋白 A 重复为主(GARP)的表达,该基因通常仅在激活的 Tregs 上表达,通过与转录激活剂融合的无核酸酶 Cas9 可在非 Treg 效应 T 细胞上诱导。进一步的分析确定,这种方法可用于映射参与基因转录的启动子序列。通过这种 CRISPR/Cas9 介导的基因编辑,我们还在几个例子中证明了人类 T 细胞功能分析的可行性:1)缺失抑制 T 细胞在再激活时的凋亡;2)钙释放激活通道的缺失,模拟免疫缺陷患者的天然遗传突变,消除了 Ca2+内流和细胞因子分泌;3)转录激活或表达增强了细胞因子信号转导,分别通过 IL-2 或 IL-7。总之,CRISPR 工具包在人 T 细胞亚群中的应用对解码其功能输出的机制具有重要意义。